Articles |

Reversal of Ischemia/Reperfusion Lung Injury by Inhibition of Polymorphonuclear Leukocytes* FREE TO VIEW

Joseph W. Barnard, PhD; K. Shappell, BA; M. Yoshitake, MS
Author and Funding Information

*From Otsuka America Pharmaceuticals Inc (Dr. Barnard and Messrs. Shappell and Yoshitake), Rockville, MD; and Rush Medical College (Dr. Barnard), Chicago, IL.

Correspondence to: Joseph W. Barnard, PhD, Maryland Research Laboratories, 9900 Medical Center Dr, Rockville, MD 20850

Chest. 1999;116(suppl_1):33S-34S. doi:10.1378/chest.116.suppl_1.33S-a
Text Size: A A A
Published online

Because polymorphonuclear leukocytes (PMNs) have been shown to mediate ischemia/reperfusion lung injury, we hypothesized that their inhibition by the agent OPC-6535, which blocks PMN adherence and superoxide production, would reverse ischemia/reperfusion injury in the isolated rat lung.

Lungs were isolated from rats using our established techniques, perfused with Earl’s balanced salt solution at 0.03 mL/g of body weight, and ventilated with air/5% CO2 except during ischemia (45 min) when flow was also stopped. Permeability was assessed by the filtration coefficient (Kf,c) and increased after 30 min of reperfusion (from 0.47 ± 0.08 to 1.27 ± 0.29 mL/min/cm H2O/100 g [p < 0.05]) and 90 min of reperfusion (1.77 ± 0.44 [p < 0.05] [n = 8]) resulting in severe edema (final wet weight, 4.24 ± 1.07 g [p < 0.05]). Treatment with 10 μM isoproterenol after 30 min of reperfusion reversed the increase (30 min of reperfusion increased Kf,c from 0.22 ± 0.02 to 0.41 ± 0.14), which was reversed by isoproterenol (back to 0.21 ± 0.06 at 90 min of reperfusion; final wet weight, 2.55 ± 1.27 g) as we have previously shown.

OPC-6535 (27 μM) also reversed reperfusion injury (Kf,c rose from 0.43 ± 0.09 at baseline to 0.97 ± 0.38 at 30 min of reperfusion, which decreased after 45 min of OPC-6535 to 0.62 ± 0.2; final wet weight, 3.18 ± 0.82 g). Kf,c in control lungs did not change (baseline 0.33 ± 0.04 to 0.21 ± 0.04 at the same time as 30 min of reperfusion to 0.21 ± 0.04 at 90 min [n = 9]). As was true for isoproterenol, OPC-6535 decreased lung myeloperoxidase (from reperfusion control values of 11,154 U/g dry lung tissue to 7,395 ± 2,303 with OPC-6535 posttreatment). These data suggest that OPC-6535 may hold promise in the treatment of acute lung injury.




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543